Top Stories

• 

  Prince Harry Tells Court Daily Mail 'Commercialized' His Life

  By Ronan Barnard

  Prince Harry said Wednesday that his private life had been "commercialized" as he made a visibly emotional appea...(read more)

• 

  US Performers Lose Challenge Over UK Royalties Legislation

  By Eddie Beaver

  Trade unions representing more than 230,000 U.S. singers and performers can't overturn secondary legislation tha...(read more)

• Beazley Rejects £7.7B Zurich Offer, Says 'Undervalues' Biz

  By Najiyya Budaly

  Beazley, an insurer with a listing in London, said Thursday that it has batted away the latest proposed takeover offer from Zurich Insurance Group of £7.7 billion ($10.4 billion), claiming it undervalues the company.

• 5 Questions For Bellevue Law Founder Florence Brocklesby

  By Hanna Vioque

  Florence Brocklesby met a few of her firm's future lawyers at her children's nursery gates. Here, the founder of Bellevue Law, who pioneered the hybrid model a decade before COVID-19, speaks to Law360 about leading an ethical, women-forward outfit.

• SFO Director's Surprise Exit Reignites Debate Over Its Future

  By Christopher Crosby

  Nick Ephgrave's surprise retirement from the Serious Fraud Office could turn up the heat on a simmering debate about the future of the agency and a potential merger with other law enforcement authorities such as the National Crime Agency, lawyers say.

• Gov't Overhaul Plan For CMA Merger Reviews Sparks Doubts

  By Najiyya Budaly

  Proposals by the government to abolish the Competition and Markets Authority's independent decision-making panel without replacing it with easier mechanisms to appeal rulings might ultimately harm the businesses that Whitehall wants to attract, experts have warned.

• Letby Avoids Further Criminal Charges Over Baby Deaths

  By Hanna Vioque

  Prosecutors said Tuesday that they would not be charging Lucy Letby with the murder and attempted murder of nine more infants because there was not enough evidence to pursue the case, as the former nurse serves out her whole-life prison sentence. 

• Mail Says Celebs 'Clutching At Straws' In Privacy Trial

  By Ronan Barnard

  The publisher of the Daily Mail newspaper said Tuesday that Prince Harry and other public figures were "clutching at straws" in their case alleging that its journalists had paid for and used unlawfully-obtained information for decades.

• Gov't Scraps Long-Awaited UK Audit Sector Reforms

  By Joel Poultney

  The government said on Tuesday that it would not push ahead with long-awaited audit and governance reforms designed to improve trust in the sector after a string of high-profile accounting scandals.

• Brazil Dam Contempt Case Has No Legal Authority, BHP Says

  By Joanne Faulkner

  BHP urged the Court of Appeal Tuesday to grant it permission to appeal against an order allowing Brazilian municipalities bringing litigation over the collapse of a dam to continue criminal contempt proceedings because it raises issues of "general public importance."

• UK Regulators Sideline Probes Into Open Banking Fees

  By Alex Davidson

  U.K. finance watchdogs said Tuesday they will not prioritize competition law investigations into future bank fees on varying regular bill payments, opting to avoid uncertainty in open banking operations.

• 'Mortgage Prisoners' Fight To Revive Core Of £800M TSB Case

  By William Janes

  Hundreds of former customers of Northern Rock suing TSB for £800 million ($1.1 billion) challenged on Tuesday a ruling that TSB did not breach their mortgage contracts by charging higher interest rates for loans the lender took over after Northern Rock's collapse.

• Paddington Bear Owner Denies Claim For Digital Royalties

  By Eddie Beaver

  The owner of the rights to Paddington Bear told a London court Tuesday that its modern royalty distribution deal formalized a gentlemen's agreement struck by the bear's creator in the 1970s and doesn't entitle another company to claim income from online merchandising.

• A&O Shearman Steers GSK's $2.2B Rapt Therapeutics Deal

  By Tom Fish

  GSK PLC said Tuesday it has agreed to acquire U.S.-based Rapt Therapeutics Inc. in a deal valued at $2.2 billion, in a bid to strengthen the British drugmaker's portfolio of respiratory, immunology and inflammation medicines.